Filing Details
- Accession Number:
- 0001645470-19-000019
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-20 16:45:45
- Reporting Period:
- 2019-03-13
- Accepted Time:
- 2019-03-20 16:45:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-13 | 2,000 | $0.02 | 21,816,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-13 | 500 | $0.02 | 21,816,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-14 | 2,000 | $0.02 | 21,818,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-14 | 5,000 | $0.02 | 21,823,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-15 | 5,000 | $0.02 | 21,828,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-15 | 5,000 | $0.02 | 21,833,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-15 | 5,000 | $0.02 | 21,838,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-15 | 5,000 | $0.02 | 21,843,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-15 | 5,000 | $0.02 | 21,848,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-18 | 2,000 | $0.02 | 21,850,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-18 | 2,000 | $0.02 | 21,852,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-18 | 5,000 | $0.02 | 21,857,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-18 | 500 | $0.02 | 21,858,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-18 | 500 | $0.02 | 21,858,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-18 | 5,000 | $0.02 | 21,863,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-18 | 5,000 | $0.02 | 21,868,623 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
